US5506337A
(en)
|
1985-03-15 |
1996-04-09 |
Antivirals Inc. |
Morpholino-subunit combinatorial library and method
|
US4797368A
(en)
|
1985-03-15 |
1989-01-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adeno-associated virus as eukaryotic expression vector
|
US5139941A
(en)
|
1985-10-31 |
1992-08-18 |
University Of Florida Research Foundation, Inc. |
AAV transduction vectors
|
US5010175A
(en)
|
1988-05-02 |
1991-04-23 |
The Regents Of The University Of California |
General method for producing and selecting peptides with specific properties
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
IE66205B1
(en)
|
1990-06-14 |
1995-12-13 |
Paul A Bartlett |
Polypeptide analogs
|
US5650489A
(en)
|
1990-07-02 |
1997-07-22 |
The Arizona Board Of Regents |
Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
|
US5384253A
(en)
|
1990-12-28 |
1995-01-24 |
Dekalb Genetics Corporation |
Genetic transformation of maize cells by electroporation of cells pretreated with pectin degrading enzymes
|
AU2515992A
(en)
|
1991-08-20 |
1993-03-16 |
Genpharm International, Inc. |
Gene targeting in animal cells using isogenic dna constructs
|
US5478838A
(en)
|
1991-09-06 |
1995-12-26 |
Yoshitomi Pharmaceutical Industries, Ltd. |
4-amino(alkyl)cyclohexane-1-carboxamide compound and use thereof
|
US5573905A
(en)
|
1992-03-30 |
1996-11-12 |
The Scripps Research Institute |
Encoded combinatorial chemical libraries
|
US5702932A
(en)
|
1992-07-20 |
1997-12-30 |
University Of Florida |
Microinjection methods to transform arthropods with exogenous DNA
|
US5288514A
(en)
|
1992-09-14 |
1994-02-22 |
The Regents Of The University Of California |
Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support
|
WO1995003402A1
(en)
|
1993-07-22 |
1995-02-02 |
Merck & Co., Inc. |
EXPRESSION OF HUMAN INTERLEUKIN-1β IN A TRANSGENIC ANIMAL
|
US5519134A
(en)
|
1994-01-11 |
1996-05-21 |
Isis Pharmaceuticals, Inc. |
Pyrrolidine-containing monomers and oligomers
|
US5593853A
(en)
|
1994-02-09 |
1997-01-14 |
Martek Corporation |
Generation and screening of synthetic drug libraries
|
US5539083A
(en)
|
1994-02-23 |
1996-07-23 |
Isis Pharmaceuticals, Inc. |
Peptide nucleic acid combinatorial libraries and improved methods of synthesis
|
US5656610A
(en)
|
1994-06-21 |
1997-08-12 |
University Of Southern California |
Producing a protein in a mammal by injection of a DNA-sequence into the tongue
|
US5525735A
(en)
|
1994-06-22 |
1996-06-11 |
Affymax Technologies Nv |
Methods for synthesizing diverse collections of pyrrolidine compounds
|
US5549974A
(en)
|
1994-06-23 |
1996-08-27 |
Affymax Technologies Nv |
Methods for the solid phase synthesis of thiazolidinones, metathiazanones, and derivatives thereof
|
US5736524A
(en)
|
1994-11-14 |
1998-04-07 |
Merck & Co.,. Inc. |
Polynucleotide tuberculosis vaccine
|
US5843780A
(en)
|
1995-01-20 |
1998-12-01 |
Wisconsin Alumni Research Foundation |
Primate embryonic stem cells
|
CA2245835A1
(en)
|
1995-06-14 |
1997-01-03 |
The Regents Of The University Of California |
Novel high affinity human antibodies to tumor antigens
|
US5569588A
(en)
|
1995-08-09 |
1996-10-29 |
The Regents Of The University Of California |
Methods for drug screening
|
US6013516A
(en)
|
1995-10-06 |
2000-01-11 |
The Salk Institute For Biological Studies |
Vector and method of use for nucleic acid delivery to non-dividing cells
|
US5780448A
(en)
|
1995-11-07 |
1998-07-14 |
Ottawa Civic Hospital Loeb Research |
DNA-based vaccination of fish
|
GB9807935D0
(en)
|
1998-04-14 |
1998-06-10 |
Univ Edinburgh |
Lineage specific cells and progenitor cells
|
US5945100A
(en)
|
1996-07-31 |
1999-08-31 |
Fbp Corporation |
Tumor delivery vehicles
|
DE69737631T3
(de)
|
1996-08-12 |
2011-08-18 |
Mitsubishi Tanabe Pharma Corp. |
MEDIKAMENTE ENTHALTEND Rho-KINASE INHIBITOREN
|
US5981274A
(en)
|
1996-09-18 |
1999-11-09 |
Tyrrell; D. Lorne J. |
Recombinant hepatitis virus vectors
|
DE69840497D1
(de)
|
1997-05-07 |
2009-03-12 |
William J Crumb |
Verwendung von Aplidine zur Behandlung von kardiovaskulären Erkrankungen
|
JP3626206B2
(ja)
|
1997-06-13 |
2005-03-02 |
ルードヴィッヒ インスティテュート フォー キャンサー リサーチ |
Smad6及びその使用
|
ATE277895T1
(de)
|
1997-07-01 |
2004-10-15 |
Warner Lambert Co |
4-brom or 4-iod-phenylamino- benzhydroxamsäurederivate und ihre anwendung als mek-inhibitoren
|
US5994624A
(en)
|
1997-10-20 |
1999-11-30 |
Cotton Incorporated |
In planta method for the production of transgenic plants
|
US5994136A
(en)
|
1997-12-12 |
1999-11-30 |
Cell Genesys, Inc. |
Method and means for producing high titer, safe, recombinant lentivirus vectors
|
US20060263382A1
(en)
|
1998-06-20 |
2006-11-23 |
Richard Hotchkiss |
Membrane-permeant peptide complexes for treatment of sepsis
|
CA2336220A1
(en)
|
1998-07-24 |
2000-02-03 |
The Carnegie Institution Of Washington |
Method for maintenance and propagation of germline stem cells using members of the tgf-.beta. family of growth factors
|
GB9819912D0
(en)
|
1998-09-11 |
1998-11-04 |
Univ Edinburgh |
Propagation and/or derivation of embryonic stem cells
|
AU2483000A
(en)
|
1999-01-07 |
2000-07-24 |
Warner-Lambert Company |
Treatment of asthma with mek inhibitors
|
US6703420B1
(en)
|
1999-03-19 |
2004-03-09 |
Bristol-Myers Squibb Pharma Company |
Amino-thio-acrylonitriles as MEK inhibitors
|
WO2000078351A1
(fr)
|
1999-06-18 |
2000-12-28 |
Mitsubishi Pharma Corporation |
Promoteurs de l'osteogenese
|
US6730293B1
(en)
|
1999-08-24 |
2004-05-04 |
Cellgate, Inc. |
Compositions and methods for treating inflammatory diseases of the skin
|
WO2001017562A1
(en)
|
1999-09-02 |
2001-03-15 |
Yamanouchi Pharmaceutical Co., Ltd. |
Osteogenesis promoting agents
|
US20020142457A1
(en)
|
1999-12-28 |
2002-10-03 |
Akihiro Umezawa |
Cell having the potentiality of differentiation into cardiomyocytes
|
US6692736B2
(en)
|
2000-03-24 |
2004-02-17 |
Cell Genesys, Inc. |
Cell-specific adenovirus vectors comprising an internal ribosome entry site
|
CN1219753C
(zh)
|
2000-07-19 |
2005-09-21 |
沃尼尔·朗伯公司 |
4-碘苯氨基苯氧肟酸的氧合酯
|
CA2441501C
(en)
|
2001-03-23 |
2010-09-14 |
Bayer Corporation |
Rho-kinase inhibitors
|
UY27224A1
(es)
|
2001-03-23 |
2002-10-31 |
Bayer Corp |
Inhibidores de la rho-quinasa
|
ATE452972T1
(de)
|
2001-05-01 |
2010-01-15 |
Ca Nat Research Council |
Induzierbares expressionssystem in eukaryotischen zellen
|
JPWO2003027277A1
(ja)
|
2001-09-21 |
2005-01-06 |
独立行政法人 科学技術振興機構 |
再プログラム化因子のスクリーニング方法、該方法によりスクリーニングされた再プログラム化因子および該再プログラム化因子を利用する方法、並びに、未分化融合細胞を分化させる方法および細胞、組織、臓器の製造方法
|
ATE554169T1
(de)
|
2001-11-02 |
2012-05-15 |
Giuliani Int Ltd |
Smad7-inhibitoren zur behandlung von krankheiten des zns
|
WO2003059913A1
(en)
|
2002-01-10 |
2003-07-24 |
Bayer Healthcare Ag |
Roh-kinase inhibitors
|
MXPA04007191A
(es)
|
2002-01-23 |
2005-03-31 |
Bayer Pharmaceuticals Corp |
Derivados de pirimidina como inhibidores de rho-quinasa.
|
ATE381557T1
(de)
|
2002-01-23 |
2008-01-15 |
Bayer Pharmaceuticals Corp |
Rho-kinase inhibitoren
|
AU2003210405A1
(en)
|
2002-03-05 |
2003-09-16 |
Artemis Pharmaceuticals Gmbh |
Inbred embryonic stem-cell derived mice
|
PT3000810T
(pt)
|
2002-03-13 |
2017-10-25 |
Array Biopharma Inc |
Derivados de benzimidazole alquilado n3 como inibidores de mek
|
WO2003082808A1
(fr)
|
2002-04-03 |
2003-10-09 |
Sumitomo Pharmaceuticals Company, Limited. |
Derives de benzamide
|
GB0210539D0
(en)
|
2002-05-08 |
2002-06-19 |
Univ Edinburgh |
Control of es cell self renewal and lineage specification, and medium therefor
|
EP1562935B1
(de)
|
2002-10-28 |
2006-09-06 |
Bayer HealthCare AG |
Heteroaryloxy-substituierte phenylaminopyrimidine als rho-kinaseinhibitoren
|
CA2506085A1
(en)
|
2002-11-15 |
2004-06-03 |
Ronald Lynn Merriman |
Combination chemotherapy comprising a mek inhibitor and capecitabine for treating cancer
|
JP2006517234A
(ja)
|
2003-02-10 |
2006-07-20 |
アムジエン・インコーポレーテツド |
バニロイド受容体リガンドおよび治療におけるこれらのリガンドの使用
|
AU2003901099A0
(en)
|
2003-03-11 |
2003-03-27 |
Es Cell International Pte Ltd. |
Methods of inducing differentiation of stem cells
|
US20050075276A1
(en)
|
2003-03-14 |
2005-04-07 |
Christopher Rudd |
Use of inhibitors of glycogen synthase-3 to augment CD28 dependent -T-cell responses
|
US20070010008A1
(en)
|
2005-06-29 |
2007-01-11 |
Tissuetech, Inc. |
Ex vivo expansion of primary animal cells
|
WO2005084158A2
(en)
|
2003-06-20 |
2005-09-15 |
The Regents Of The University Of California |
Polypeptide transduction and fusogenic peptides
|
CN103602633A
(zh)
|
2003-10-03 |
2014-02-26 |
福田惠一 |
由干细胞分化诱导心肌细胞的方法
|
EP2468729B1
(en)
|
2003-10-15 |
2013-12-25 |
Ube Industries, Ltd. |
Novel indazole derivative
|
CA2542276A1
(en)
|
2003-10-16 |
2005-04-28 |
The University Court Of The University Of Edinburgh |
Control of es cell self-renewal and lineage specification, and medium therefor
|
JP4768628B2
(ja)
|
2003-11-19 |
2011-09-07 |
アレイ バイオファーマ、インコーポレイテッド |
Mekの二環系阻害剤及びその使用方法
|
US20070141703A1
(en)
|
2003-11-19 |
2007-06-21 |
Stanley Edouard G |
Methods for producing blood products from pluripotent cells in cell culture
|
US20070269412A1
(en)
|
2003-12-02 |
2007-11-22 |
Celavie Biosciences, Llc |
Pluripotent cells
|
EP1713775A4
(en)
|
2004-01-30 |
2009-08-12 |
Smithkline Beecham Corp |
CHEMICAL COMPOUNDS
|
AU2005241009A1
(en)
|
2004-04-21 |
2005-11-17 |
Mcmaster University |
Myosin light chain kinase inhibitors and their use
|
KR20070083559A
(ko)
|
2004-08-13 |
2007-08-24 |
더 유니버시티 오브 죠지아 리서치 파운데이션, 인코포레이티드 |
인간 배아 줄기세포에서의 자가재생 및 분화를 위한 조성물및 방법
|
US20080268533A1
(en)
|
2004-08-25 |
2008-10-30 |
University Of Georgia Research Foundation, Inc. |
Methods and Compositions Utilizing Myc and Gsk3Beta to Manipulate the Pluripotency of Embryonic Stem Cells
|
WO2006088867A2
(en)
|
2005-02-15 |
2006-08-24 |
Medistem Laboratories, Incorporated |
Method for expansion of stem cells
|
SG177981A1
(en)
|
2005-05-18 |
2012-02-28 |
Array Biopharma Inc |
4-(phenylamino)-6-oxo-1, 6-dihydropyridazine-3-carboxamide derivatives as mek inhibitors for the treatment of hyperproliferative diseases
|
JP4395193B2
(ja)
|
2005-08-01 |
2010-01-06 |
ニューポテンシャル,インコーポレイテッド |
回復能を有する再プログラムされた細胞の作製
|
CA2621161A1
(en)
|
2005-09-08 |
2007-03-15 |
The Government Of The United States Of America As Represented By The Sec Retary Of The Department Of Health And Human Services |
Methods for promoting stem cell proliferation and survival
|
US8217042B2
(en)
|
2005-11-11 |
2012-07-10 |
Zentaris Gmbh |
Pyridopyrazines and their use as modulators of kinases
|
BRPI0619794B8
(pt)
|
2005-12-13 |
2022-06-14 |
Univ Kyoto |
Uso de um fator de reprogramação, agente para a preparação de uma célula-tronco pluripotente induzida a partir de uma célula somática e métodos para preparar uma célula- tronco pluripotente induzida método e para preparar uma célula somática e uso de células-tronco pluripotentes induzidas
|
US20090227032A1
(en)
|
2005-12-13 |
2009-09-10 |
Kyoto University |
Nuclear reprogramming factor and induced pluripotent stem cells
|
GB0601538D0
(en)
|
2006-01-26 |
2006-03-08 |
Univ Birmingham |
Epigenetic analysis
|
EP1992360A4
(en)
|
2006-02-01 |
2010-02-17 |
Univ Tokyo |
USE IN ASSOCIATION OF A TGF-BETA SIGNAL INHIBITOR AND ANTITUMMER AGENT
|
US7541186B2
(en)
|
2006-02-22 |
2009-06-02 |
University Of Washington |
Method of generating human retinal progenitors from embryonic stem cells
|
GB0615327D0
(en)
|
2006-03-30 |
2006-09-13 |
Univ Edinburgh |
Culture medium containing kinase inhibitors and uses thereof
|
EP1999249B8
(en)
|
2006-03-30 |
2012-02-15 |
The University Court Of The University of Edinburgh |
Culture medium containing kinase inhibitors. and uses thereof
|
US8741643B2
(en)
|
2006-04-28 |
2014-06-03 |
Lifescan, Inc. |
Differentiation of pluripotent stem cells to definitive endoderm lineage
|
GB2452186B
(en)
|
2006-05-02 |
2011-01-26 |
Wisconsin Alumni Res Found |
Method of differentiating stem cells into cells of the endoderm and pancreatic lineage
|
MX2009000285A
(es)
|
2006-06-30 |
2009-06-08 |
Schering Corp |
Piperidinas sustituidas que incrementan la actividad de p53 y usos de las mismas.
|
PT2044056E
(pt)
|
2006-07-14 |
2012-12-05 |
Novartis Ag |
Derivados de pirimidina como inibidores de alk-5
|
US20080020014A1
(en)
|
2006-07-19 |
2008-01-24 |
Paul Consigny |
Implantable devices containing nuclear receptor ligands for the treatment of vascular and related disorders
|
JP2008099662A
(ja)
|
2006-09-22 |
2008-05-01 |
Institute Of Physical & Chemical Research |
幹細胞の培養方法
|
CN101563449A
(zh)
|
2006-09-22 |
2009-10-21 |
理化学研究所 |
干细胞培养基及干细胞培养方法
|
GB0622395D0
(en)
|
2006-11-09 |
2006-12-20 |
Univ Cambridge Tech |
Methods relating to pluripotent cells
|
JP5419279B2
(ja)
|
2007-01-17 |
2014-02-19 |
ウィスコンシン アラムニ リサーチ ファンデーション |
改良された幹細胞の培養
|
WO2008088882A2
(en)
|
2007-01-19 |
2008-07-24 |
The J. David Gladstone Institutes |
Methods of generating cardiomyocytes
|
AU2008211103B2
(en)
|
2007-01-30 |
2014-05-08 |
University Of Georgia Research Foundation, Inc. |
Early mesoderm cells, a stable population of mesendoderm cells that has utility for generation of endoderm and mesoderm lineages and multipotent migratory cells (MMC)
|
KR20090122946A
(ko)
|
2007-02-27 |
2009-12-01 |
주식회사 프로셀제약 |
줄기세포의 자가-재생을 촉진하고 분화를 억제하기 위한 세포투과성 nanog 및 oct4의 병합 용도
|
EP3449923A1
(en)
|
2007-03-07 |
2019-03-06 |
MEI Pharma, Inc. |
Combination of benzimidazole anti-cancer agent and a second anti-cancer agent
|
WO2008126932A2
(en)
|
2007-04-09 |
2008-10-23 |
Riken |
Epigenetical regulation of brain plasticity
|
CA2684460C
(en)
|
2007-04-18 |
2017-01-03 |
Hadasit Medical Research Services & Development Limited |
Stem cell-derived retinal pigment epithelial cells
|
US7878210B2
(en)
|
2007-06-04 |
2011-02-01 |
Philip Morris Usa Inc. |
Cellulose acetate fiber modification
|
US8648069B2
(en)
|
2007-06-08 |
2014-02-11 |
Abbvie Inc. |
5-substituted indazoles as kinase inhibitors
|
US9213999B2
(en)
|
2007-06-15 |
2015-12-15 |
Kyoto University |
Providing iPSCs to a customer
|
JP2008307007A
(ja)
|
2007-06-15 |
2008-12-25 |
Bayer Schering Pharma Ag |
出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞
|
KR20100059789A
(ko)
|
2007-06-29 |
2010-06-04 |
셀룰러 다이내믹스 인터내셔널, 인코포레이티드 |
배아줄기세포 배양을 위한 자동화 방법 및 장치
|
US20120282229A1
(en)
|
2007-08-01 |
2012-11-08 |
Christian Kannemeier |
Non-viral delivery of transcription factors that reprogram human somatic cells into a stem cell-like state
|
WO2009032194A1
(en)
|
2007-08-31 |
2009-03-12 |
Whitehead Institute For Biomedical Research |
Wnt pathway stimulation in reprogramming somatic cells
|
CN101617043B
(zh)
|
2007-10-31 |
2014-03-12 |
国立大学法人京都大学 |
核重编程方法
|
US20110151447A1
(en)
|
2007-11-06 |
2011-06-23 |
Children's Medical Center Corporation |
Method to produce induced pluripotent stem (ips) cells from non-embryonic human cells
|
JP4604076B2
(ja)
|
2007-11-07 |
2010-12-22 |
国立大学法人静岡大学 |
燃料電池用電解質膜
|
WO2009073523A2
(en)
|
2007-11-29 |
2009-06-11 |
Children's Hospital Of Orange County |
De-differentiation of human cells
|
US20110190729A1
(en)
|
2007-11-30 |
2011-08-04 |
Cytomatrix Pty Ltd |
Methods of inducing pluripotency involving sox2 protein
|
EP2224940A1
(en)
|
2007-11-30 |
2010-09-08 |
Cytomatrix PTY LTD |
Methods of inducing pluripotency involving oct4 protein
|
BRPI0908708A2
(pt)
|
2008-03-17 |
2019-09-24 |
Scripps Research Inst |
métodos para produzir células tronco pluripotentes induzidas a partir de células não pluripotentes de mamífero, para triar quanto a agentes que induzam a reprogramação ou desdiferenciação de células de mamífero dentro das células tronco pluripotentes, para triar quanto a células de mamífero com características de células tronco pluripotente, para induzir a expressão de oct4 em uma célula e para induzir células não pluripotentes em células pluripotentes, mistura, célula de mamífero, métodos para produzir células tronco pluripotentes induzidas a partir de células não pluripotentes de mamífero, para triar quanto a agentes que induzam a reprogramação ou desiferenciação de células de mamífero dentro das células tronco pluripotentes, para triar quanto a células de mamífero com características de célula tronco pluripotente, para induzir a expressão de oct4 em uma célula e para induzir células não pluripotentes em células pluripotentes, mistura, célula de mamífero, composição, e, kit
|
JP2011516042A
(ja)
|
2008-03-17 |
2011-05-26 |
へルムホルツ・ツェントルム・ミュンヘン−ドイチェス・フォルシュングスツェントルム・ヒューア・ゲズントハイト・ウント・ウムヴェルト(ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング) |
部位特異的組み換えを用いて無ベクター誘導多能性幹(iPS)細胞を作製するベクターおよびその方法
|
CN101550406B
(zh)
|
2008-04-03 |
2016-02-10 |
北京大学 |
制备多潜能干细胞的方法,试剂盒及用途
|
EP2307539B1
(en)
*
|
2008-07-30 |
2014-11-19 |
Kyoto University |
Method of efficiently establishing induced pluripotent stem cells
|
US8298825B1
(en)
|
2008-08-25 |
2012-10-30 |
The General Hospital Corporation |
TGF-beta receptor inhibitors to enhance direct reprogramming
|
CA2907326A1
(en)
|
2008-11-04 |
2010-05-14 |
Chad Green |
Stem cell aggregate suspension compositions and methods for differentiation thereof
|
US8691573B2
(en)
|
2008-12-03 |
2014-04-08 |
The Scripps Research Institute |
Stem cell cultures
|
SG172160A1
(en)
|
2008-12-17 |
2011-07-28 |
Scripps Research Inst |
Generation and maintenance of stem cells
|
US20120122212A1
(en)
|
2009-03-06 |
2012-05-17 |
Marica Grskovic |
Tgf-beta pathway inhibitors for enhancement of cellular reprogramming of human cells
|
CA2758003A1
(en)
|
2009-04-13 |
2010-10-21 |
The Regents Of The University Of California |
Methods and compositions for stem cell cultures
|
AU2010253844A1
(en)
|
2009-05-27 |
2012-02-02 |
Center Of Regenerative Medicine Of Barcelona, Spain |
Generation of genetically corrected disease-free induced pluripotent stem cells
|
EP2438159B1
(en)
|
2009-05-29 |
2018-10-03 |
Kyoto University |
Method for selecting clone of induced pluripotent stem cells
|
US8524498B2
(en)
|
2009-05-29 |
2013-09-03 |
The General Hospital Corporation |
Methods and compositions for homologous recombination in human cells
|
JP5376478B2
(ja)
|
2009-08-07 |
2013-12-25 |
国立大学法人京都大学 |
効率的な人工多能性幹細胞の樹立方法
|
CN105861446B
(zh)
|
2009-10-16 |
2021-10-01 |
斯克里普斯研究所 |
多能细胞的诱导
|
LT2494039T
(lt)
|
2009-10-31 |
2019-07-25 |
Genesis Technologies Limited |
Ląstelių perprogramavimo būdai ir jų panaudojimas
|
CN102597221B
(zh)
|
2009-11-04 |
2015-03-11 |
细胞动力国际有限公司 |
使用化学品的游离重编程
|
ES2779048T3
(es)
*
|
2009-11-12 |
2020-08-13 |
Technion Res & Dev Foundation |
Medios de cultivo, cultivos celulares y métodos de cultivo de células madre pluripotentes en un estado indiferenciado
|
JP5827220B2
(ja)
*
|
2010-01-22 |
2015-12-02 |
国立大学法人京都大学 |
人工多能性幹細胞の樹立効率改善方法
|
WO2011103343A2
(en)
|
2010-02-17 |
2011-08-25 |
Biotime Inc. |
Methods for telomere length and genomic dna quality control analysis in pluripotent stem cells
|
CN102844428B
(zh)
|
2010-03-05 |
2015-09-02 |
德克萨斯心脏研究所 |
Ets2和mesp1由成纤维细胞生成心脏祖细胞
|
ES2624780T3
(es)
|
2010-03-31 |
2017-07-17 |
The Scripps Research Institute |
Reprogramación de células
|
WO2011158852A1
(ja)
|
2010-06-15 |
2011-12-22 |
国立大学法人東京大学 |
誘導型多能性幹細胞の製造方法
|
EP2582794B2
(en)
|
2010-06-15 |
2024-04-24 |
FUJIFILM Cellular Dynamics, Inc. |
Generation of induced pluripotent stem cells from small volumes of peripheral blood
|
US20110306516A1
(en)
|
2010-06-15 |
2011-12-15 |
The New York Stem Cell Foundation |
Methods for producing induced pluripotent stem cells
|
US8765470B2
(en)
|
2010-08-04 |
2014-07-01 |
Cellular Dynamics International, Inc. |
Reprogramming immortalized B-cells to induced pluripotent stem cells
|
CN114164167A
(zh)
|
2010-12-22 |
2022-03-11 |
菲特治疗公司 |
用于单细胞分选与增强ipsc重新编程的细胞培养平台
|
US9458131B2
(en)
*
|
2011-11-08 |
2016-10-04 |
Emory University |
Compounds and compositions used to epigenetically transform cells and methods related thereto
|
AU2012347534B2
(en)
|
2011-12-08 |
2018-01-25 |
Fred Hutchinson Cancer Research Center |
Compositions and methods for enhanced generation of hematopoietic stem/progenitor cells
|
WO2013159103A1
(en)
*
|
2012-04-20 |
2013-10-24 |
Whitehead Institute For Biomedical Research |
Programming and reprogramming of cells
|
WO2013176197A1
(ja)
|
2012-05-22 |
2013-11-28 |
国立大学法人 東京大学 |
抗原特異的t細胞の製造方法
|
US9166832B1
(en)
|
2013-10-04 |
2015-10-20 |
Altera Corporation |
Methods and apparatus for decision feedback equalization adaptation
|
EP3604499A1
(en)
|
2014-03-04 |
2020-02-05 |
Fate Therapeutics, Inc. |
Improved reprogramming methods and cell culture platforms
|
CA3001917A1
(en)
|
2015-10-16 |
2017-04-20 |
Fate Therapeutics, Inc. |
Platform for the induction & maintenance of ground state pluripotency
|
EP3371314B1
(en)
|
2015-11-04 |
2023-07-05 |
Fate Therapeutics, Inc. |
Genomic engineering of pluripotent cells
|